US Stock MarketDetailed Quotes

ELTX Elicio Therapeutics

Watchlist

4.230
+0.240+6.02%

Close Sep 6 16:00 ET

45.58MMarket Cap-1122P/E (TTM)

Elicio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

5.77%-8.93M

-48.94%-12.12M

-47.41%-32.69M

-36.01%-9.9M

3.75%-5.18M

-9.48M

-8.14M

7.35%-22.18M

-7.28M

-5.39M

Net income from continuing operations

4.34%-7.23M

-47.30%-11.83M

-24.77%-35.2M

-34.55%-8.95M

-48.10%-10.66M

---7.56M

---8.03M

-6.85%-28.21M

---6.65M

---7.2M

Operating gains losses

-301.33%-3.62M

1,815.74%1.85M

-197.89%-927K

-102.44%-16K

-72.78%98K

---901K

---108K

1,688.07%947K

--657K

--360K

Depreciation and amortization

-41.52%293K

163.64%290K

10.69%1.17M

-2.72%286K

-7.14%273K

--501K

--110K

320.36%1.06M

--294K

Other non cash items

----

-68.41%1.14M

-13.79%75K

--0

--719K

--342K

439.09%3.6M

--87K

--1.08M

Change In working capital

150.64%1.27M

-307.37%-2.76M

62.00%-57K

12.51%-1.63M

15,986.67%4.77M

---2.52M

---678K

-117.19%-150K

---1.86M

---30K

-Change in prepaid assets

-146.58%-180K

222.30%1.25M

61.04%-729K

-45.76%-688K

170.14%1.05M

---73K

---1.02M

-419.42%-1.87M

---472K

---1.5M

-Change in payables and accrued expense

248.13%1.99M

-465.94%-3.7M

173.05%2.24M

151.45%266K

533.71%2.3M

---1.34M

--1.01M

-34.98%820K

---517K

---531K

-Change in other current liabilities

-45.98%-254K

-49.69%-244K

-54.21%-825K

-50.96%-237K

-62.99%-251K

---174K

---163K

-21.75%-535K

---157K

---154K

-Change in other working capital

70.18%-277K

86.79%-67K

-151.67%-742K

-35.47%-970K

--1.66M

---929K

---507K

--1.44M

---716K

----

Cash from discontinued investing activities

Operating cash flow

5.77%-8.93M

-48.94%-12.12M

-47.41%-32.69M

-36.01%-9.9M

3.75%-5.18M

---9.48M

---8.14M

7.35%-22.18M

---7.28M

---5.39M

Investing cash flow

Cash flow from continuing investing activities

-240.00%-42K

117.65%3K

95.11%-32K

-45K

30K

-17K

-24.49%-654K

-95K

Net PPE purchase and sale

-240.00%-42K

117.65%3K

95.11%-32K

--0

---45K

--30K

---17K

-24.49%-654K

---95K

--0

Cash from discontinued investing activities

Investing cash flow

-240.00%-42K

117.65%3K

95.11%-32K

--0

---45K

--30K

---17K

-24.49%-654K

---95K

--0

Financing cash flow

Cash flow from continuing financing activities

-98.53%316K

9.80%11.02M

82.12%38.61M

-37.35%7M

-99.33%59K

21.51M

10.04M

9.32%21.2M

11.18M

8.78M

Net issuance payments of debt

--0

--10M

--0

--10M

--0

Net common stock issuance

302.00%303K

--5.06M

--6.85M

--7M

--0

---150K

--0

Net preferred stock issuance

----

--0

----

327.07%21.12M

--11.11M

--8.84M

Proceeds from stock option exercised by employees

-51.85%13K

14,805.00%5.96M

54.88%127K

--0

198.36%60K

--27K

--40K

-21.36%82K

--65K

---61K

Net other financing activities

----

--21.64M

--3K

---1K

----

Cash from discontinued financing activities

Financing cash flow

-98.53%316K

9.80%11.02M

82.12%38.61M

-37.35%7M

-99.33%59K

--21.51M

--10.04M

9.32%21.2M

--11.18M

--8.78M

Net cash flow

Beginning cash position

28.24%13.21M

69.97%14.3M

-16.24%8.41M

273.07%17.2M

1,739.06%22.36M

--10.3M

--8.41M

-33.54%10.05M

--4.61M

--1.22M

Current changes in cash

-171.72%-8.65M

-158.12%-1.1M

460.94%5.89M

-176.06%-2.89M

-252.37%-5.17M

--12.07M

--1.88M

67.84%-1.63M

--3.81M

--3.39M

Effect of exchange rate changes

----

--0

--2K

----

--0

End cash Position

-79.83%4.51M

28.24%13.21M

69.97%14.3M

273.07%17.2M

--22.36M

--10.3M

-16.23%8.41M

--8.41M

--4.61M

Free cash flow

5.37%-8.97M

-48.63%-12.12M

-43.48%-32.76M

-34.26%-9.9M

2.91%-5.23M

---9.48M

---8.16M

6.67%-22.83M

---7.37M

---5.39M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	5.77%-8.93M	-48.94%-12.12M	-47.41%-32.69M	-36.01%-9.9M	3.75%-5.18M	-9.48M	-8.14M	7.35%-22.18M	-7.28M	-5.39M
Net income from continuing operations	4.34%-7.23M	-47.30%-11.83M	-24.77%-35.2M	-34.55%-8.95M	-48.10%-10.66M	---7.56M	---8.03M	-6.85%-28.21M	---6.65M	---7.2M
Operating gains losses	-301.33%-3.62M	1,815.74%1.85M	-197.89%-927K	-102.44%-16K	-72.78%98K	---901K	---108K	1,688.07%947K	--657K	--360K
Depreciation and amortization	-41.52%293K	163.64%290K	10.69%1.17M	-2.72%286K	-7.14%273K	--501K	--110K	320.36%1.06M	--294K	--294K
Other non cash items	----	----	-68.41%1.14M	-13.79%75K	--0	--719K	--342K	439.09%3.6M	--87K	--1.08M
Change In working capital	150.64%1.27M	-307.37%-2.76M	62.00%-57K	12.51%-1.63M	15,986.67%4.77M	---2.52M	---678K	-117.19%-150K	---1.86M	---30K
-Change in prepaid assets	-146.58%-180K	222.30%1.25M	61.04%-729K	-45.76%-688K	170.14%1.05M	---73K	---1.02M	-419.42%-1.87M	---472K	---1.5M
-Change in payables and accrued expense	248.13%1.99M	-465.94%-3.7M	173.05%2.24M	151.45%266K	533.71%2.3M	---1.34M	--1.01M	-34.98%820K	---517K	---531K
-Change in other current liabilities	-45.98%-254K	-49.69%-244K	-54.21%-825K	-50.96%-237K	-62.99%-251K	---174K	---163K	-21.75%-535K	---157K	---154K
-Change in other working capital	70.18%-277K	86.79%-67K	-151.67%-742K	-35.47%-970K	--1.66M	---929K	---507K	--1.44M	---716K	----
Cash from discontinued investing activities
Operating cash flow	5.77%-8.93M	-48.94%-12.12M	-47.41%-32.69M	-36.01%-9.9M	3.75%-5.18M	---9.48M	---8.14M	7.35%-22.18M	---7.28M	---5.39M
Investing cash flow
Cash flow from continuing investing activities	-240.00%-42K	117.65%3K	95.11%-32K	0	-45K	30K	-17K	-24.49%-654K	-95K	0
Net PPE purchase and sale	-240.00%-42K	117.65%3K	95.11%-32K	--0	---45K	--30K	---17K	-24.49%-654K	---95K	--0
Cash from discontinued investing activities
Investing cash flow	-240.00%-42K	117.65%3K	95.11%-32K	--0	---45K	--30K	---17K	-24.49%-654K	---95K	--0
Financing cash flow
Cash flow from continuing financing activities	-98.53%316K	9.80%11.02M	82.12%38.61M	-37.35%7M	-99.33%59K	21.51M	10.04M	9.32%21.2M	11.18M	8.78M
Net issuance payments of debt	--0	--0	--10M	--0	--0	--0	--10M	--0	--0	--0
Net common stock issuance	302.00%303K	--5.06M	--6.85M	--7M	--0	---150K	--0	--0	--0	--0
Net preferred stock issuance	----	----	--0	--0	----	----	----	327.07%21.12M	--11.11M	--8.84M
Proceeds from stock option exercised by employees	-51.85%13K	14,805.00%5.96M	54.88%127K	--0	198.36%60K	--27K	--40K	-21.36%82K	--65K	---61K
Net other financing activities	----	----	--21.64M	--3K	---1K	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-98.53%316K	9.80%11.02M	82.12%38.61M	-37.35%7M	-99.33%59K	--21.51M	--10.04M	9.32%21.2M	--11.18M	--8.78M
Net cash flow
Beginning cash position	28.24%13.21M	69.97%14.3M	-16.24%8.41M	273.07%17.2M	1,739.06%22.36M	--10.3M	--8.41M	-33.54%10.05M	--4.61M	--1.22M
Current changes in cash	-171.72%-8.65M	-158.12%-1.1M	460.94%5.89M	-176.06%-2.89M	-252.37%-5.17M	--12.07M	--1.88M	67.84%-1.63M	--3.81M	--3.39M
Effect of exchange rate changes	----	----	--0	--0	--2K	----	----	--0	--0	--0
End cash Position	-79.83%4.51M	28.24%13.21M	69.97%14.3M	69.97%14.3M	273.07%17.2M	--22.36M	--10.3M	-16.23%8.41M	--8.41M	--4.61M
Free cash flow	5.37%-8.97M	-48.63%-12.12M	-43.48%-32.76M	-34.26%-9.9M	2.91%-5.23M	---9.48M	---8.16M	6.67%-22.83M	---7.37M	---5.39M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall